Business Segment Information

9 Months Ended

Sep. 30, 2012

Business Segment Information

Business Segment Information

16.Business Segment Information

The Company has determined that it has four operating segments based on the information reviewed by the Chief Operating Decision Maker, representing each of its four groups or divisions: Bruker BioSpin group, Bruker CALID group, Bruker MAT group, and Bruker Energy & Supercon Technologies division. The Bruker BioSpin group is in the business of designing, manufacturing and distributing enabling life science tools based on magnetic resonance technology. The Bruker CALID group combines the Bruker Daltonics Life-Science and Clinical, Chemical and Applied Markets, Bruker Detection and Bruker Optics divisions and is in the business of designing, manufacturing, and distributing mass spectrometry and chromatography instruments and solutions for life sciences, including proteomics, metabolomics, and clinical research applications. Our mass spectrometry and chromatography instruments also provide solutions for applied markets that include food safety, environmental analysis and petrochemical analysis. Bruker CALID also designs, manufactures, and distributes various analytical instruments for CBRNE detection and research, as well as analytical, research and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The Bruker MAT group is in the business of manufacturing and distributing advanced X-ray, spark-optical emission spectroscopy, atomic force microscopy and stylus and optical metrology instrumentation used in non-destructive molecular, materials and elemental analysis. The Bruker Energy & Supercon Technologies division is in the business of developing and producing low temperature superconductor and high temperature superconductor materials for use in advanced magnet technology and energy applications as well as linear accelerators, accelerator cavities, insertion devices, superconducting fault current limiters, other accelerator components and specialty superconducting magnets for physics and energy research and a variety of other scientific applications.

The Company’s reportable segments are organized by the types of products and services provided. The Company has combined the Bruker BioSpin, Bruker CALID and Bruker MAT operating segments into the Scientific Instruments reporting segment because each has similar economic characteristics, product processes and services, types and classes of customers, methods of distribution and regulatory environments.

Management evaluates segment operating performance and allocates resources based on operating income (loss). The Company uses this measure because it helps provide an understanding of its core operating results. Selected business segment information is presented below (in millions):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2012			2011			2012			2011
Revenue:
Scientific Instruments	$	408.9		$	394.6		$	1,184.0		$	1,108.3
Energy & Supercon Technologies	42.4			27.7			98.4			79.8
Eliminations (a)	(3.5		)	(3.9		)	(8.3		)	(11.5		)
Total revenue	$	447.8		$	418.4		$	1,274.1		$	1,176.6
Operating Income (Loss):
Scientific Instruments	$	48.0		$	41.3		$	106.3		$	107.3
Energy & Supercon Technologies	14.4			(3.3		)	13.4			(3.6		)
Corporate, eliminations and other (b)	(2.1		)	(0.5		)	(2.9		)	(1.8		)
Total operating income	60.3			37.5			116.8			101.9
Interest and other income (expense), net	(2.7		)	1.9			(13.0		)	(8.8		)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	$	57.6		$	39.4		$	103.8		$	93.1

(a)	Represents product and service revenue between reportable segments.
(b)	Represents corporate costs and eliminations not allocated to the reportable segments.

Total assets by segment are as follows (in millions):

	September 30,			December 31,
	2012			2011
Assets:
Scientific Instruments	$	1,739.4		$	1,675.0
Energy & Supercon Technologies	127.2			104.4
Eliminations and other (a)	(66.6		)	(68.9		)
Total assets	$	1,800.0		$	1,710.5

(a) Assets not allocated to the reportable segments and eliminations of intercompany transactions.